|
CH602664A5
(en)
|
1973-06-14 |
1978-07-31 |
Sandoz Ag |
2-Tert. amino-alkylamino-pyrimidine derivs.
|
|
ZA835878B
(en)
*
|
1982-08-23 |
1985-03-27 |
Warner Lambert Co |
Cardiotonic agents
|
|
GB2263639A
(en)
|
1992-01-28 |
1993-08-04 |
Merck & Co Inc |
Substituted pyrimidinones as neurotensin antagonists
|
|
DE4425616A1
(de)
*
|
1994-07-20 |
1996-01-25 |
Basf Ag |
Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung
|
|
BR9711098B1
(pt)
|
1996-07-01 |
2011-10-04 |
|
compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas.
|
|
EP1301490A2
(en)
|
2000-07-18 |
2003-04-16 |
Neurogen Corporation |
5-substituted 2-aryl-4-pyrimidinones
|
|
TW200300349A
(en)
|
2001-11-19 |
2003-06-01 |
Sankyo Co |
A 4-oxoqinoline derivative
|
|
EP1503993A4
(en)
|
2002-05-09 |
2006-05-03 |
Cytokinetics Inc |
COMPOUNDS, METHODS AND COMPOSITIONS
|
|
AU2003231799A1
(en)
|
2002-05-23 |
2003-12-12 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
|
JP2004339159A
(ja)
|
2003-05-16 |
2004-12-02 |
Sankyo Co Ltd |
４−オキソキノリン誘導体を含有する医薬組成物
|
|
JP2007505121A
(ja)
|
2003-09-08 |
2007-03-08 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
|
WO2005041888A2
(en)
|
2003-11-03 |
2005-05-12 |
Cytokinetics, Inc. |
Pyrimidin-4-one compounds, compositions and methods
|
|
EP1697331A4
(en)
|
2003-12-19 |
2010-08-04 |
Merck Sharp & Dohme |
INHIBITORS OF MITOTIC KINESINE
|
|
US7732613B2
(en)
|
2005-09-14 |
2010-06-08 |
Bristol-Myers Squibb Company |
Met kinase inhibitors
|
|
WO2007037543A1
(ja)
|
2005-09-29 |
2007-04-05 |
Banyu Pharmaceutical Co., Ltd. |
ビアリールアミド誘導体
|
|
CA2630884A1
(en)
|
2005-11-30 |
2007-06-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-met and uses thereof
|
|
EP2016056A4
(en)
|
2006-04-21 |
2010-11-10 |
Univ Boston |
IONIC VISCOELASTIC AND VISCOELASTIC SALTS
|
|
JP2007308441A
(ja)
*
|
2006-05-22 |
2007-11-29 |
Sumitomo Chemical Co Ltd |
含複素環化合物及びその用途
|
|
WO2008052861A2
(de)
|
2006-10-10 |
2008-05-08 |
Proionic Production Of Ionic Substances Gmbh & Co Keg |
Verfahren zur herstellung von 1,3 -hetero-aromatischen carbonaten
|
|
PL2079707T3
(pl)
|
2006-10-10 |
2015-05-29 |
Proionic Gmbh |
Sposób wymiany 1,3-hetero-aromatycznych 2-karboksylanów z wodą
|
|
TW200845994A
(en)
|
2007-01-12 |
2008-12-01 |
Smithkline Beecham Corp |
N-substituted glycine derivatives: prolyl hydroxylase inhibitors
|
|
US8314087B2
(en)
|
2007-02-16 |
2012-11-20 |
Amgen Inc. |
Nitrogen-containing heterocyclyl ketones and methods of use
|
|
WO2009129120A2
(en)
|
2008-04-15 |
2009-10-22 |
Rfs Pharma, Llc |
Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
|
|
US20110253929A1
(en)
|
2008-12-22 |
2011-10-20 |
Basf Se |
Mixtures of hydrophobic and hydrophilic ionic liquids and use thereof in liquid ring compressors
|
|
CA2762680C
(en)
|
2009-05-21 |
2018-04-17 |
Chlorion Pharma, Inc. |
Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
|
|
US9212130B2
(en)
|
2010-08-10 |
2015-12-15 |
Shionogi & Co., Ltd. |
Heterocyclic derivative and pharmaceutical composition comprising the same
|
|
SG195086A1
(en)
|
2011-05-31 |
2013-12-30 |
Merck Patent Gmbh |
Compounds containing hydrido-tricyano-borate anions
|
|
AU2012265220A1
(en)
|
2011-05-31 |
2014-01-16 |
Merck Patent Gmbh |
Electrolyte formulations
|
|
US20140005181A1
(en)
*
|
2012-06-21 |
2014-01-02 |
Sanford-Burnham Medical Research Institute |
Small molecule antagonists of the apelin receptor for the treatment of disease
|
|
WO2014004676A1
(en)
|
2012-06-26 |
2014-01-03 |
Ironwood Pharmaceuticals, Inc. |
Use of faah inhibitors as neuroprotective agents in the cns
|
|
ES2623528T3
(es)
*
|
2012-09-21 |
2017-07-11 |
Sanofi |
Derivados de amida de ácido benzoimidazolcarboxílico para tratar enfermedades metabólicas o cardiovasculares
|
|
DE102012021452A1
(de)
|
2012-10-31 |
2014-04-30 |
Merck Patent Gmbh |
Salze mit Trihydroperfluoralkoxybutansulfonat- oder Trihydroperfluoralkoxypropansulfonat-Anion
|
|
WO2014160185A2
(en)
|
2013-03-14 |
2014-10-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
|
WO2014207100A1
(en)
|
2013-06-27 |
2014-12-31 |
Basf Se |
A process for coating paper with cellulose using a solution containing cellulose
|
|
CN105324376B
(zh)
|
2013-06-27 |
2017-06-23 |
辉瑞大药厂 |
杂芳族化合物及其作为多巴胺d1配体的用途
|
|
ES2906062T3
(es)
|
2013-11-29 |
2022-04-13 |
Proionic Gmbh |
Procedimiento para la unión de un material termoplástico por medio de radiación de microondas
|
|
WO2015184011A2
(en)
|
2014-05-28 |
2015-12-03 |
Sanford-Burnham Medical Research Institute |
Agonists of the apelin receptor and methods of use thereof
|
|
PE20170664A1
(es)
*
|
2014-06-06 |
2017-06-10 |
Res Triangle Inst |
Agonistas del receptor de apelina(apj) y usos de los mismos
|
|
WO2016074757A1
(de)
|
2014-11-11 |
2016-05-19 |
Merck Patent Gmbh |
Verfahren zur herstellung von mono- und bis(perfluoralkyl)fluorophosphatsalzen und deren säuren
|
|
EP3287443B1
(en)
|
2015-04-24 |
2021-10-27 |
Shionogi & Co., Ltd |
6-membered heterocyclic derivative and pharmaceutical composition comprising same
|
|
AU2016263564B2
(en)
|
2015-05-20 |
2019-12-05 |
Amgen Inc. |
Triazole agonists of the APJ receptor
|
|
CA2988147C
(en)
|
2015-06-03 |
2023-06-13 |
Bristol-Myers Squibb Company |
4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders
|
|
KR101711744B1
(ko)
|
2015-07-16 |
2017-03-02 |
경희대학교 산학협력단 |
옥사디아졸 유도체, 이의 제조방법 및 이를 포함하는 전자수송층
|
|
EP3380970B1
(en)
|
2015-11-24 |
2023-01-04 |
Sanford Burnham Prebys Medical Discovery Institute |
Novel azole derivatives as apelin receptor agonist
|
|
BR112018010720A8
(pt)
|
2015-12-04 |
2019-02-26 |
Bristol Myers Squibb Co |
agonistas do receptor de apelina e métodos de uso
|
|
ES2854733T3
(es)
|
2015-12-16 |
2021-09-22 |
Bristol Myers Squibb Co |
Heteroarilhidroxipirimidinonas como agonistas del receptor APJ
|
|
TWI744301B
(zh)
|
2016-03-24 |
2021-11-01 |
美商必治妥美雅史谷比公司 |
做為apj促效劑之6-羥基-4-側氧-1,4-二氫嘧啶-5-甲醯胺
|
|
WO2017218633A1
(en)
|
2016-06-14 |
2017-12-21 |
Bristol-Myers Squibb Company |
6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1h)-one as apj agonists
|
|
ES2844184T3
(es)
|
2016-06-14 |
2021-07-21 |
Bristol Myers Squibb Co |
4-hidroxi-3-sulfonilpiridin-2(1H)-onas como agonistas del receptor de APJ
|
|
CN110072850B
(zh)
|
2016-10-14 |
2023-07-21 |
百时美施贵宝公司 |
3-磺酰基-5-氨基吡啶-2,4-二醇apj激动剂
|